Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica

  1. Date of occurrence of the event: Feb 13, 2019
  2. Company name: OBI Pharma Inc.
  3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office
  4. Reciprocal shareholding ratios: N/A
  5. Name of mass media: Page C5 of Economy Daily News on Feb 13, 2019
  6. Content reported: News article by Economy Daily News regarding the collaborative publication by OBI Pharma Inc. and Academia Sinica
  7. Cause of occurrence: Clarification on news article
  8. Countermeasures: Information regarding the press release has been made available to the public on Feb 12, 2019. For more detail, please visit OBI’s corporate website at https://www.obipharma.com. Publication related information can be found on PNAS’s official website at https://www.pnas.org/content/early/2019/02/08/1816946116.
  9. Any other matters that need to be specified: New drug development is a long process associated with high costs. It is not a guaranteed success, which may increase the risk of investment. Investors shall make prudent judgments and investments.